These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31030672)

  • 1. Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort.
    Arellano-Campos O; Gómez-Velasco DV; Bello-Chavolla OY; Cruz-Bautista I; Melgarejo-Hernandez MA; Muñoz-Hernandez L; Guillén LE; Garduño-Garcia JJ; Alvirde U; Ono-Yoshikawa Y; Choza-Romero R; Sauque-Reyna L; Garay-Sevilla ME; Malacara-Hernandez JM; Tusie-Luna MT; Gutierrez-Robledo LM; Gómez-Pérez FJ; Rojas R; Aguilar-Salinas CA
    BMC Endocr Disord; 2019 Apr; 19(1):41. PubMed ID: 31030672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.
    Sevilla-González MDR; Merino J; Moreno-Macias H; Rojas-Martínez R; Gómez-Velasco DV; Manning AK
    Cardiovasc Diabetol; 2021 Feb; 20(1):56. PubMed ID: 33639941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk score model of type 2 diabetes prediction for rural Chinese adults: the Rural Deqing Cohort Study.
    Chen X; Wu Z; Chen Y; Wang X; Zhu J; Wang N; Jiang Q; Fu C
    J Endocrinol Invest; 2017 Oct; 40(10):1115-1123. PubMed ID: 28474301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
    Chávez-Talavera O; Wargny M; Pichelin M; Descat A; Vallez E; Kouach M; Bigot-Corbel E; Joliveau M; Goossens JF; Le May C; Hadjadj S; Hanf R; Tailleux A; Staels B; Cariou B
    Metabolism; 2020 Feb; 103():154042. PubMed ID: 31785259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing different anthropometric indices and their optimal cutoffs for prediction of type 2 diabetes and impaired fasting glucose in Asians: The Jinchang Cohort Study.
    Ding J; Chen X; Bao K; Yang J; Liu N; Huang W; Huang P; Huang J; Jiang N; Cao J; Cheng N; Wang M; Hu X; Zheng S; Bai Y
    J Diabetes; 2020 May; 12(5):372-384. PubMed ID: 31642584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 15. Six-year follow-up study on the association between white blood cell count and fasting blood glucose level in Chinese adults: A community-based health examination survey.
    Zang X; Meng X; Wang Y; Jin X; Wu T; Liu X; Geng H; Xu W; Wang Y; Teng F; Qiu Q; Yang M; Liang J
    Diabetes Metab Res Rev; 2019 May; 35(4):e3125. PubMed ID: 30614185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes primary prevention program: New insights from data analysis of recruitment period.
    Gagliardino JJ; Elgart JF; Bourgeois M; Etchegoyen G; Fantuzzi G; Ré M; Ricart JP; García S; Giampieri C; González L; Suárez-Crivaro F; Kronsbein P; Angelini JM; Martínez C; Martínez J; Ricart A; Spinedi E
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28843031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in diabetes prevalence and corresponding risk factors - findings from 3- and 6-year follow-up of PURE Poland cohort study.
    Zatońska K; Basiak-Rasała A; Różańska D; Karczewski M; Wołyniec M; Szuba A; Połtyn-Zaradna K
    BMC Public Health; 2020 Jun; 20(1):843. PubMed ID: 32493306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study.
    Mukai N; Doi Y; Ninomiya T; Hata J; Yonemoto K; Iwase M; Iida M; Kiyohara Y
    Diabetes Care; 2009 Dec; 32(12):2288-93. PubMed ID: 19729523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.